Cadila Healthcare informs about press release

24 Sep 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated September 24, 2020 titled ‘Zydus Cadila receives tentative approval from USFDA for Palbociclib Capsules’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

1036.80 -13.55 (-1.29%)
29-May-2024 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1473.70
Dr. Reddys Lab 5935.15
Cipla 1483.00
Zydus Lifesciences 1036.80
Lupin 1595.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.